According to a note out of Bell Potter,
it expects no sales revenue, an EBITDA loss of $46 million, and a net loss of $55 million.
Goldman Sachs
EBITDA loss of $65 million and a net loss of $46.5 million.
What was the result?
Net Loss of $64.91 mil, which was higher than both projected by Bell Potter and Goldman
More significantly, LTR's cash position as at 30 June 2024 was just $122 mil. This was before its drawdown of LG Loan.
FY 2025 outlook
Goldman is forecasting spodumene production of 146kt, which it expects to underpin revenue of $143 million.
However, this won't be enough to make Liontown profitable according to Goldman. It expects another year of losses before it becomes profitable in FY 2026. The broker is forecasting an EBITDA loss of $224 million and a net loss of $162 million.
Bell Potter doesn't agree with this view. It believes Liontown will generate positive EBITDA of $32 million and a loss of $58 million in FY 2025.
